Guest guest Posted December 22, 2010 Report Posted December 22, 2010 Flu virus still packs plenty of surprises DAVID STEINKRAUS journalTimes.com , December 22, 2010 It has been more than a year since the panic over H1N1 influenza, since the vaccine shortages, the declaration of a global pandemic and fears that there would be a repeat of 1918 when influenza killed between 50 and 100 million people worldwide. With a global pandemic in the past and another flu season upon us, what do we face this year? What have we learned? Are better vaccines and more responsive vaccine production in the offing? The answers are not much, so far not much, and maybe. Those answers are indefinite because of the nature of the influenza virus itself. It is an ancient foe with a history stretching back into time along with that of humanity, and it is a changeable foe. Like humans themselves, the virus has a key survival advantage in its ability to change and adapt. The virus First isolated in 1933, the influenza virus consists of eight strands of RNA which is a complement to DNA and serves as a template for proteins. The flu virus makes eight proteins. What makes it such a difficult target is that it changes constantly which is why this year's flu vaccine is different from last year's. The other factor is that when two flu viruses meet in the same animal, the bits of genetic material can combine in new ways. The H1N1 virus which appeared last year and caused such concern was a combination of two genes from a swine flu, two genes from a bird flu, one human gene, and then genes from European swine for the protein involved in assembling the finished virus and for making the enzyme that cuts the assembled virus free of its host cell. " All those genes have been seen before but not in that particular combination, " said Lamb, professor of molecular and cellular biology in the Department of Molecular Biosciences at Northwestern University in ton, Ill. That recombination, properly called a reassortment, occurred in some animal. No one is certain how a European swine was involved nor where the reassortment happened. " So that fact is all of a sudden this virus initiated an epidemic in Mexico, and then that spread worldwide. That's it. That's all we know, " said Yoshihiro Kawaoka. He is a professor of virology in the University of Wisconsin School of Veterinary Medicine and a leading experts on influenza. One key difference in last year's H1N1 flu is that younger people were much more susceptible than usual. Typically it is the very old and the very young who are most at risk from flu. " I don't think it was any more virulent. In fact, most of the people got really mild illnesses, " said Dr. Fauci, director of the National Institute of Allergy and Infectious Diseases. Missing knowledge What we know about the flu virus is all on the outside. Scientists characterize the virus by two molecules, as in H1N1. The H is hemagglutinin which allows the virus to identify and attach to cells. The N is neuraminidase, an enzyme that cuts the connection with the host cell and sets the new virus free to float off and infect a new cell. We don't understand what makes the virus more or less transmissible in humans. If the virus can attach to cells in the upper airway, it can be transmitted easily. What happens then depends on the body's ability to fight the disease. " We know what some of the virulence factors are, but I think it's fair to say we don't know what they all are, " Lamb said. What we're really missing is what is happening inside the cell, all the interactions between the viral proteins and the cell it infects. Vaccine We have a vaccine system that is not very speedy. In the spring researchers take samples of the viruses in circulation, and then pharmaceutical manufacturers spend several months growing the viruses in chicken eggs, purifying them, inactivating them and packaging the doses for use in humans. But this is an obviously slow process, and it cannot be quickly adapted to meet the threat of a new virus such as H1N1. One impediment to reforming the vaccine system is economic. Only two primary companies make vaccine, and they have a heavy investment in the current technology, Kawaoka said. In theory one could make a vaccine more quickly in a cell culture than in an egg, he said, but such techniques would still have to be proven through clinical trials in humans. And, Lamb said, there is the problem of scaling up for production; what works on a lab bench in small batches becomes a massive engineering problem when manufacturers try to meet the production demands for the nation's population. " You should never have to grow the virus at all, " Fauci said. Ideally we would use the techniques of genetic analysis to break down the genome of a new virus, then add bits of DNA to the genome of a cell so that it produces the viral proteins for a vaccine. In August, researches from the NIAID reported progress on creating a universal vaccine, in other words one that could work against more than one type of flu. The research team created antibodies from parts of the flu genome that change little from year to year. Boosted by a dose of seasonal flu virus, this universal vaccine was effective against H1N1 strains dating back to 1934, the team reported in Science magazine. Eternal evolution Given the fact that the flu virus has only a few strands of genetic material, and that not every part of its genome changes, one might think that after a while the virus will run out of possible combinations and we can catch up. " Won't happen. It's evolution, " Kawaoka said. " We may not call it influenza virus any more in 1,000 or 1 million years from now. " But the virus will still be with us as it has been with us for what we know of human history. Pathogens do become less virulent over time, he said; they must or they risk wiping themselves out as they destroy their hosts. Influenza and we are old friends, perhaps a bit too cozy because familiarity in this case is breeding not contempt but a certain amount of indifference that leaves us vulnerable to the sudden appearance of a new, and deadly, flu. http://www.journaltimes.com/lifestyles/health-med-fit/article_6519be90-0d3e-11e0\ -9450-001cc4c03286.html Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.